AlzeCure Pharma AB (publ) (FRA:AC6)

Market Cap	14.33M -29.7%
Revenue (ttm)	n/a
Net Income	-5.40M
EPS	-0.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0842
Previous Close	0.0848
Day's Range	0.0842 - 0.0842
52-Week Range	0.0840 - 0.4370
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857 and ACD680 that...

• Industry: Pharmaceutical Preparations
• Founded: 2012
• Employees: 10
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AC6

Financial Performance

Financial numbers in SEK